Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Drugs of Today (Barcelona, Spain : 1998)|January 1, 2004
Insulin glargine versus NPH insulin in patients with type 1 diabetesRobert RatnerThe Journal of Clinical Endocrinology and Metabolism|September 6, 2008
Approach to the patient with prediabetesVanita R Aroda, Robert RatnerDiabetes/Metabolism Research and Reviews|April 13, 2011
The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a reviewVanita R Aroda, Robert RatnerJournal of Clinical Hypertension (Greenwich, Conn.)|April 7, 2011
Hypertension complicating diabetic pregnancies: pathophysiology, management, and controversiesShannon D Sullivan, Jason G Umans, Robert RatnerCurrent Diabetes Reports|November 1, 2011
Gestational diabetes: implications for cardiovascular healthShannon D Sullivan, Jason G Umans, Robert RatnerDiabetes Care|August 29, 2006
Ethnic differences in perinatal outcome of gestational diabetes mellitusJana Kaida Silva, Joseph Keawe'aimoku Kaholokula, Robert Ratner, et al.Cardiovascular Diabetology|March 18, 2011
Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetesRobert Ratner, Jenny Han, Dawn Nicewarner, et al.Diabetes Care|March 29, 2005
Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention programRobert Ratner, Ronald Goldberg, Steven Haffner, et al.Annals of Internal Medicine|April 20, 2005
The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trialTrevor J Orchard, Marinella Temprosa, Ronald Goldberg, et al.Vascular Health and Risk Management|May 14, 2009
Risk factors associated with methamphetamine use and heart failure among native Hawaiians and other Pacific Island peoplesMarjorie K Mau, Karynna Asao, Jimmy Efird, et al.Pageof 3